About EDGAR Online
|
Login
Dashboard
Today
Company
Industry
Search
Screener
Analytics
The following is an excerpt from a 8-K SEC Filing, filed by KING PHARMACEUTICALS INC on 11/4/2005.
Next Section
Previous Section
-- Use Sections To Navigate Through The Document --
FORM 8-K
Item 1.01 Entry into a Material Definitive Agreement.
Item 7.01 Regulation FD Disclosure.
SIGNATURE
EXHIBIT 10.1
EXHIBIT 10.2
EXHIBIT 10.3
EXHIBIT 99.1
KING PHARMACEUTICALS INC - 8-K - 20051104 - SIGNATURES
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 4, 2005
KING PHARMACEUTICALS, INC.
By:
/s/ Brian A. Markison
Brian A. Markison
President and Chief Executive Officer
© 1995-2009
EDGAR Online, Inc.
All rights reserved • NASDAQ:
EDGR
•
Solutions for Corporations
•
Terms of Use
•
Privacy Statement
Next Section
Previous Section